ATRX and neoplasm: Metastatic patient with ALT positive tumours showed a longer disease specific survival.5 6 Additionally, in previous studies, neither DAXX/ATRX loss nor ALT activation in primary tumours correlated with decreased overall patient survival.4 5 The emerging double role of ALT depending on the disease status of advance is intriguing; yet the reasons for this are still unknown.